BARCELONA – A new prostate cancer study has showed that biomarker-driven targeted treatments improve the survival of patients with metastatic disease.
BARCELONA – A new prostate cancer study has showed that biomarker-driven targeted treatments improve the survival of patients with metastatic disease.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.